RecruitingPhase 2NCT04192253

Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize)

Studying Vulvar carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Netherlands Cancer Institute
Principal Investigator
Frederic Amant, MD, PHD
NKI-AvL
Intervention
Paclitaxel and Carboplatin(drug)
Enrollment
51 enrolled
Eligibility
18 years · FEMALE
Timeline
2020 – 2029

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04192253 on ClinicalTrials.gov

Other trials for Vulvar carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Vulvar carcinoma →

← Back to all trials